Safety and Efficacy Study of AC-3933 in Adults With Mild to Moderate Alzheimer's Disease

Status:
Completed

Trial end date:
2008-09-01

Target enrollment:

Participant gender:

The purpose of this study is to investigate efficacy and safety of different doses of AC-3933 in patients with mild to moderate Alzheimer's Disease.

Phase 2

Sunovion